EQT Corporation Common Stock vs GeneDx Holdings Corp — how do they compare? EQT Corporation Common Stock trades at $52.7 (market cap $33.11B), while GeneDx Holdings Corp trades at $67.6 (market cap $2.02B). The key difference: EQT Corporation Common Stock is far larger — about 16.4× GeneDx Holdings Corp's market cap, and EQT Corporation Common Stock pays a 1.25% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 0 Days and GeneDx Holdings Corp for 19 Days on average.
| EQT | WGS | |
|---|---|---|
Market Cap | $33.11B | $2.02B |
Volume | 7,642,959 | 734,640 |
Sector | Energy | Health |
52-Week High | $67.93 | $167.51 |
52-Week Low | $48.56 | $34.51 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $38.66B | $2.05B |
Dividend Yield | 1.25% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.
The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.
Read more on EQT →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →